Abiopharma

New Form 6-K - ONCOLYTICS BIOTECH INC Filed: 2025-08-28 AccNo: 0001129928-25-000070 Size: 31 KB

New Form 6-K - LakeShore Biopharma Co., Ltd. Filed: 2025-08-28 AccNo: 0001213900-25-081400 Size: 36 KB

Streamex (BSGM) to Participate in the 5th Annual Needham Virtual Crypto 1x1 Conference on September 4th

A New Press Release from Oncolytics Biotech, Inc

Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference

Halozyme - Halozyme to Participate at Upcoming Investor Conferences

Teva Pharmaceutical Industries Ltd. - Teva Announces FDA Approval and Launch of GenericSaxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss

Moleculin Announces Exercise of Warrants for $6.0 Million Gross Proceeds

CytoDyn to Present at the H.C. Wainwright 27th Annual Global Investment Conference

CorMedix to Participate in Upcoming Investor Conferences

Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss

Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025

New Form 6-K - Galmed Pharmaceuticals Ltd. Filed: 2025-08-28 AccNo: 0001493152-25-012420 Size: 2 MB

Dominari Holdings Files $2 Billion Shelf to Support Strategic Expansion

New Form 8-K - Imunon, Inc. Filed: 2025-08-28 AccNo: 0001493152-25-012417 Size: 235 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 9.01: Financial Statements and Exhibits